H.C. Wainwright adjusted the firm’s price target on Arqit Quantum (ARQQ) to $22 from $2 and keeps a Buy rating on the shares to reflect the ...
H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on MediWound (MDWD) to $25 from $28 and keeps a Buy rating on ...
H.C. Wainwright lowered the firm’s price target on Electra Battery Materials (ELBM) to $1.30 from $1.40 and keeps a Buy rating on the shares. The firm cites Electra’s recent financing that yielded ...
H.C. Wainwright raised the firm’s price target on Iris Energy (IREN) to $16 from $13 and keeps a Buy rating on the shares. The company is ...
H.C. Wainwright has recently reduced Eyenovia Inc (EYEN) stock to Neutral rating, as announced on November 18, 2024, according to Finviz. Earlier, on March 1, 2021, Northland Capital had initiated the ...
H.C. Wainwright lowered the firm’s price target on BioLineRx (BLRX) to $9 from $21 and keeps a Buy rating on the shares after the company ...
H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Alector (ALEC) to $7 from $35 and keeps a Buy rating on the shares. The ...
H.C. Wainwright analyst Andres Maldonado raised the firm’s price target on Scholar Rock (SRRK) to $50 from $40 and keeps a Buy rating on the ...
H.C. Wainwright raised the firm’s price target on Eton Pharmaceuticals (ETON) to $15 from $11 and keeps a Buy rating on the shares after the ...
H.C. Wainwright analyst Vernon Bernardino downgraded Cassava Sciences (SAVA) to Neutral from Buy without a price target after the company ...
H.C. Wainwright initiated coverage of Redwire (RDW) with a Buy rating and $18 price target Redwire is positioned to be key beneficiary of ...
To access the live webcast of the fireside chat, please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a ...